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Photo-Induced Cytotoxicity and Anti-Metastatic Activity of 
Ruthenium(II)-Polypyridyl Complexes Functionalized with 
Tyrosine or Tryptophan   
Vadde Ramu,a Sunil Aute,a Nandaraj Taye,b Rweetuparna Guha,a Michael G. Walker,c Devaraj 
Mogare,b Apoorva Parulekar,b Jim A Thomas*,c  Samit Chattopadhyay*b,d and Amitava Das*a,e 
The synergistic effect of oxygen, light, and photosensitizer (PS) has found applications in medicine for the treatment of 
cancer through photodynamic therapy (PDT). Induction of apoptosis to cancerous cells will prevent tumor metastasis that 
spreads cancer cells to the neighboring organs/tissues. Herein, we report the two apoptotic Ru(II)-polypyridyl complexes 
that are functionalized with pendent amino acid moieties tyrosine (1) and tryptophan (2), respectively. These two water 
soluble complexes were found to interact strongly (Ka
1
 = (1.18 ± 0.28)105 M-1 and Ka
2 = (1.57 ± 0.77)105 M-1) with CT-DNA. 
Isothermal titration calorimetry (ITC) studies revealed that these complexes bind to CT-DNA through an entropically driven 
process. Both the complexes showed photo-induced cytotoxicity and exhibits apoptotic activity under photo-irradiation 
conditions. The comet assay indicated that these complexes can damage cellular DNA, which was attributed to the 
significant buildup of 1O2 level even on irradiation with low intensity light (10 J/cm
2, λRange 450 - 480 nm). This 
photoinduced DNA damage and apoptosis in A549 cells were induced by reactive oxygen species (ROS) and occurred 
through up-regulation of apoptotic marker caspase-3. Control experiments under the dark condition revealed an 
insignificant cytotoxicity towards these cells for two photosensitive molecules.
1.Introduction 
According to the World Health Organization (WHO), cancer is 
the leading cause of death all around the world.1 One of the 
defining features of cancer is the rapid creation of abnormal 
cells that grow beyond their usual boundaries, which can then 
invade adjoining parts of the body and spread to other organs, 
the latter process is known as metathesis. Photodynamic 
therapy (PDT) is non-invasive and one of the most extensively 
used techniques for dermatological diseases and various types 
of cancers, which could be used to control and selectively treat 
solid tumors.2–4 The main advantage of PDT over traditional 
therapies such as surgery, radiation and chemotherapy are 
that PDT produces fewer side effects. PDT requires a 
photosensitizer or photosensitizing agent (PS) that is 
therapeutically activated in the presence of light.5 Ideally, the 
PDT reagent should not show any such activity in the dark. The 
activity of such PDT reagents mainly depends on the efficiency 
of the PS molecule or fragment in generating long-lived excited 
state. On excitation of the PS moiety at an appropriate 
wavelength, energy or electron transfer process eventually 
lead to the generation of reactive oxygen species (ROS) like 
superoxide anion (O2
•ˉ), hydroxyl radical (HO•ˉ), hydrogen 
peroxide and singlet oxygen (1O2). Such ROS species are known 
to be cytotoxic to living cells and can be judiciously utilized for 
targeted singlet oxygen chemotherapy. Tumor metastasis is a 
multistep biological process that allows cancer cells to move 
away from the primary tumor, survive in the circulation 
system, locate in distal sites and grow.6 Thus, more recently it 
has been argued that effective treatment for cancer largely 
depends on therapeutics that not only induces cell cycle arrest 
but also possess anti-metastatic activity. Commercially 
available PS agents such as hematoporphyrins and its 
derivatives (HpD) generally suffer from drawbacks such as low 
solubility in aqueous solutions and weak absorption band at 
630 nm. This necessitates the use of high light doses of 100-
200 J/cm2 to achieve the desired control of tumor growth. 
Also, common PDT drugs like Porfimer sodium can cause 
severe side effects, as they are retained in the body for about 
4 months and results in skin photosensitivity.7 More recently, 
the European Union has approved the use of meso-tetra 
hydroxyphenyl chlorin (mTHPC) as a PS for PDT application.5–7 
However, these agents suffer from poor stability in 
physiological conditions and also photobleach on photo- 
irradiation.5,8  These drawbacks limit the use of these reagents 
for PDT applications; thus, there is a definite scope for 
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developing appropriate reagents that can overcome foresaid 
disadvantages. After the successful entry of ruthenium-based 
drugs (NAMI-A and KP1019) into human clinical trials, there is 
a burgeoning interest in developing Ru(II)-based novel 
anticancer drugs with new and improved function.8,9 The 
possibility of achieving high solubility by choosing appropriate 
counter anions or through appropriate functionalization of the 
coordinated ligands has led to the design of new Ru(II)-
polypyridyl complexes for use of anti-cancer and anti-
metastatic drugs.10,11 These complexes are attractive choices 
for use as photodynamic therapeutic reagents and they also 
possesses visible light excitation, reasonably long-lived triplet 
excited states, and higher stability towards photobleaching.7 
Recent reports suggested that the conjugation of biologically 
relevant molecules to the Ru(II)-polypyridyl complexes can 
improve cellular internalization.12,13 Ru(II)-polypyridyl 
complexes with appropriately functionalized bpy derivative 
can enhance lipophilicity and can lead to more efficient 
internalization.14–17 Herein, we investigated the use of two 
Ru(II)-polypyridyl based reagents with pendant tyrosine or 
tryptophan moiety as efficient PDT reagents. Photo-induced 
cytotoxicity, anti-metastatic property, cellular uptake and ROS-
mediated DNA cleaving pathways for these two complexes (1 
and 2) are described. Significantly it has been found that these 
systems are active as PDT sensitizers at light doses as low as 10 
J/cm2. 
2. Results and discussion 
Synthesis of 1 and 2 was achieved by following previously 
reported literature procedures.18,19 Both complexes were 
characterized using a range of spectroscopic and analytical 
techniques. All these spectroscopic data, as well as the results 
of elemental analysis, confirm the desired purity for both 
complexes utilized in our studies (fig. S8-11). The 
photophysical properties of these two complexes are well 
established and this is the primary reason for choosing them 
for our studies. Tyrosine is a non-essential amino acid that 
plays a crucial role in the protein synthesis and acts as a 
receiver of phosphate groups in biological systems that are 
transferred by way of protein kinases (so-called receptor 
tyrosine kinases).20 Also, it is involved in the mechanism of 
photosynthetic oxidation of water into molecular oxygen in 
photosystem II (PSII).21 The tryptophan moiety that is utilized 
in designing complex 2 is an essential amino acid that cannot 
be synthesized by higher organisms. Tyrosine and tryptophan 
derivatives are known to readily cross the blood–brain barrier 
and facilitate cellular internalization.22 On the other hand, 
Ru(II)-polypyridyl complexes are known to generate reactive 
oxygen species (ROS) up on irradiation into their MLCT band in 
the visible region of the spectrum.23–26 As outlined above, such 
ROS species damage biomolecules and are therefore cytotoxic 
to living cells.27–29 Since these two complexes are 
functionalized with amino acid moieties to enhance cellular 
internalization and possess well-defined 
photophysical/physicochemical properties, their capability to 
photo-induced damage to the DNA and function as cytotoxic 
agents was investigated.  
 
Figure 1. Chemical structures of complex 1 and 2. 
DNA binding studies.  
Water soluble complexes 1 and 2 with Clˉ as counter anion 
were obtained via anion metathesis. The interactions of 
complexes 1 and 2 with CT-DNA were investigated using UV-
Visible and fluorescence spectroscopy. The addition of small 
aliquots of CT-DNA to the buffer solution containing 1 or 2 led 
to an appreciable hypochromic shift in the π→π* (290 nm) 
based transition, while slight change was registered for the 
MLCT (450 nm)-based absorption band (Fig. S1) for the 
respective complex. Such changes are not uncommon for 
reagents that are not bound to DNA structure though 
intercalative mode of binding.30,31 Luminescence studies 
revealed that addition of CT-DNA to the aq. buffer solutions of 
1 and 2 led to the enhancement in the fluorescence intensity 
of the respective complexes. The binding affinity Ka, and site 
size S for the respective complexes were calculated by fitting 
the obtained data from UV-Visible and fluorescence 
spectroscopic titrations into McGhee Von-Hippel model (table 
1). The binding parameters evaluated using these two different 
optical titration methods were found to be in good agreement. 
The relatively high affinities observed suggest that the 
interaction of these systems with DNA is not solely due to 
electrostatics. 
Table 1. Binding parameters that were evaluated from UV-Visible and fluorescence 
titrations for 1 and 2 with CT-DNA. 
                  1                                                     2 
 Titration        Ka[Mol
-1]          S[bp]               Ka[Mol
-1]        S[bp]                      
 Absorbance        3.2 X 105                    0.8                  5.3 X 105         1.0                      
 Luminescence            1.6 X 105            0.9                2.1 X 105               0.9   
          
Isothermal titration calorimetry studies with CT-DNA.  
Binding constants and other thermodynamic parameters for 
the interaction of complexes 1 and 2 with CT-DNA were also 
evaluated using isothermal titration calorimetry (ITC) 
measurements. Relevant thermographs are displayed in 
figures 2a and 2b. The binding affinity of 1 (Ka
1 = 1.18 X 105 M-
1) and 2 (Ka
2 = 1.57 X 105 M-1) towards CT-DNA were in good 
agreement with those obtained from VU-Visible and 
luminescence titrations. Since, ITC and spectroscopic 
techniques used two different binding models to calculate the 
binding constant (Ka) and site size (N), it is not unreasonable to 
see a minor difference in the values evaluated for Ka and N 
(bp) following two different techniques. Data are shown in 
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table 2 clearly reveal that the binding process was entropically 
driven with the best fit for the integrated heat data being 
obtained using a single set of identical sites model.  
 
Figure 2. ITC binding profile plots for binding of 1 and 2 with CT-DNA. 
This thermodynamic profile is indicative of non-covalent 
interactions between DNA and the complexes and is consistent 
with hydrogen bonding. Since both complexes contain amino 
acid moieties with a set of donor and acceptor sites these 
observations are not unexpected: we have previously 
demonstrated that somewhat related systems possessing 
hydrogen bonding sites can bind DNA with high affinities.32 All 
these observations suggested that 1 and 2 interact with CT-
DNA predominantly through groove binding and certainly not 
through intercalation. To corroborate this result, we 
performed the viscosity measurements with CT-DNA which 
also confirmed the groove binding of complex 1 and 2 (Fig. S2). 
This is consistent with the observed evidence of hydrogen-
bonding, as this interaction would require the amino-acid 
based ligand to sit in a DNA groove so that it can make close 
contact with base pairs. 
Plasmid DNA photo-cleavage: Gel electrophoresis studies. 
We also investigated possible mechanisms of cell death caused 
by complexes 1 and 2. To assess the DNA-damaging ability of 1 
and 2 upon photo-irradiation, we conducted the gel 
electrophoresis experiment with pUC19 plasmid DNA after 
incubation with 1 or 2. Agarose gel images of pUC19 plasmid 
DNA (Fig. 3) clearly revealed that the photo-irradiated of 
plasmid DNA samples incubated with 1 and 2 leads to 
conversion of supercoiled DNA (SC) into nicked circular 
form(NC). No such DNA cleavage has been found when the 
dark incubated samples ran on the agarose gel. It is well 
documented in the literature that Ru(II)-polypyridyl complexes 
can convert water or molecular oxygen into the respective ROS 
species (OH• or 1O2) following an energy transfer process 
involving their 3MLCT state.5,28–31 To understand the role of 
ROS which could be responsible for the observed pUC19 
plasmid DNA cleavage, the control experiments were 
performed by incubating the plasmid DNA 1 (Fig. 3a) or 2 (Fig. 
3b) along with DMSO (a OH• radical scavenger) or D2O (which 
enhances 1O2 lifetime) or NaN3 (an 
1O2 quencher) under the 
same photo-irradiation conditions. These reaction mixtures 
were subjected to agarose gel electrophoresis (Lanes 1-5, Fig. 
3a for complex 1; Fig. 3b for 
 
Figure 3. Electrophoresis in agarose gel of pUC19 plasmid DNA with 1 (a) and 2 (b) 
following photo-irradiation for 4 h (lanes 1 - 5) and incubation in the dark conditions for 
4 h (lane 6-10) in presence of different inhibitors. Lane C: Control plasmid DNA, lane 1: 
DNA with 1/2 (50 µM), lane 2: DNA with 1/2 (100 µM), lane 3: DNA with 1/2 (100 µM) 
in presence of D2O, lane 4: DNA with 1/2 (100 µM) in presence of DMSO, Lane 5: DNA 
with 1/2 (100 µM) in presence of NaN3. For experiments [DNA] = 40 µg/mL, [NaN3] = 
100 mM, [D2O] = 100 mM, [DMSO] = 200 mM; Lanes 6-10 represents the samples 
incubated in dark with same experimental conditions that were followed for lanes 1-5. 
complex 2). Simultaneous control experiments were 
performed after incubation in the dark under otherwise 
identical experimental conditions (Lanes 6-10, Fig. 3b for 
complex 1, Fig. 3b for complex 2). It is evident from Fig. 3 that, 
on incubation with complex 1 or 2 under irradiation, pUC19 
plasmid DNA is converted from SC to NC DNA. For experiments 
that were performed in the presence of D2O, a distinct 
increase in the SC to NC (lane 3) forms was observed. For 
experiments that were performed after incubation with 
DMSO, the pattern of the damage to the plasmid remained 
unchanged (lane 4). These observations indicate that the 
photo-irradiation of 1 or 2 was generated in-situ ROS species 
(1O2 and not OH
•). To further confirm this, the samples were 
co-incubated with NaN3, (efficient scavenger for 
1O2, lane 5). It 
is evident from lane 5 that the presence of NaN3 results in the 
inhibition of conversion of SC into NC. Thus, gel 
electrophoresis results clearly reveal that both 1 and 2 damage 
plasmid DNA in the presence of light through an in-situ 
generation of 1O2. Results of the control experiments also 
confirm that these two complexes fail to generate any DNA 
damage in the dark. To prove the in-situ generation of 1O2 on 
photo-irradiation of 1 and 2, we have recorded its 
phosphorescence band for 1O2 that appears in the NIR region 
at 1275 nm (Fig. S3). 
Evaluation of 
1
O2 production ability by 1 and 2. 
For PDT application, relatively high quantum yield of 1O2 (~0.5) 
is desired.10 We utilized the N,N-dimethyl-4-nitrosoaniline 
(RNO)/imidazole assay for evaluating the relative quantum 
yield efficiency for 1O2 generation by complexes 1 and 2 on 
irradiation with a visible light source having λ ≥ 450 nm (table 
2, Fig. S4). Singlet oxygen (produced in-situ) reacts with 
imidazole and leads to the generation of a tetrannular 
intermediate species, which eventually, quenches the 
absorption band for RNO at 440 nm either in acetonitrile or 
water (Fig. S4b, d, g and h). The universal standard, 
phenalenone was used as the reference for the determination 
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of singlet oxygen quantum yield.36 The nature of the solvent 
had pronounced influence on the efficiency photosensitization 
and generation of 1O2. 
 
Table 2. Singlet oxygen quantum yield for complex 1, 2 and [Ru(bpy)2(dmbpy)]
2+ 
  Complex    Water     Acetonitrile   
   1    0.20          0.80 
   2    0.25          0.72 
 [Ru(bpy)2(dmbpy)]
2+  0.32          0.57  
          
Eventually the 1O2 quantum yields were calculated using the 
equation 1 and data for respective complexes are provided in 
table 2. The measured quantum yield values of these two 
complexes were found to be comparable for analogous 
compounds reported in literature.28 
 
 
equation 1. 
Light-induced cytotoxicity: MTT assay 
Since photoexcited Ru(II)-polypyridyl complexes are known to 
generate ROS, we then examined the light-induced cytotoxicity 
of complexes 1 and 2 towards the two different cancer cell 
lines. Live human lung cancer (A549) and colon cancer 
(Hct116) cells were incubated with 1 and 2 for 4 h in the dark 
and photo-irradiation conditions. The cells were photo-
irradiation at the MLCT wavelength of 1 and 2 with visible light 
source (λRange ~ 450 - 480 nm having the flux of 10 J/cm
2) under 
otherwise identical conditions. MTT assay studies revealed 
(Fig. 4) that these two complexes are non-toxic in dark 
conditions (IC50 > 300 µM) with more than 85 % of the cells 
surviving even at 300 µM concentration. However, upon 
photo-irradiation, the calculated IC50 values were 25 and 28 
µM respectively for complexes 1 and 2 (table. S1). A 
substantial difference in light and dark IC50 values suggested 
that these complexes could have possible application as PDT 
agent. 
It is worth mentioning that literature reports suggest most 
initial drug screening is performed with two-dimensional cell 
culture.9,37–39 A solid cancer, such as those of the breast, colon, 
stomach, lung and liver, is a tumor mass that is hypoxic at the 
center and denser than the surrounding tissue. In this context, 
3D cell culture model has been developed, where 3D cell 
culture model performs better than the commonly used 2D 
models in capturing the complexity of in-vivo processes within 
the tumor microenvironment and provide a more realistic 
physiological environment than traditional monolayer 
cultures.37,40 3D tumor spheroids mimic the pathophysiology of 
tumors, including hypoxic/necrotic regions as well as 
mimicking the changes in cell shape, the high proportions of 
quiescent cells, alterations in gene expression profiles, and 
diminished permeability to drugs.41 Spheroids exhibit the 
phenomena of multicellular resistance (MCR), which is 
manifested in the diminished efficacy of chemotherapeutics 
similar to in-vivo activities.42 Thus, to examine the cytotoxicity 
of these two photo-responsive Ru(II)-polypyridyl complexes 
towards such 3D tumors under more biologically relevant 
conditions, treatment efficacy was examined with 3D tumor 
model by generating tumor spheroids with A549 and Hct116 
cells. Spheroids of ca. 600 μm in diameter were dosed with 
compounds 1 and 2 (10 – 300 µM) and then these tumors 
were either kept in the dark for control experiments or were 
kept 
 
Figure 4. Photo-induced cytotoxicity of 1 (a, c) and 2 (b, d) in 2D tumors of A549 cells 
(top) and Hct116 (bottom) after photo-irradiation for 4 h (green bars), and in dark for 4 
h (red bars). 
under photo-irradiation (Fig. S5). Significant photo-induced 
cytotoxicity was observed for both complexes (1 and 2) with 
an IC50 values two different cell lines are provided in the table 
S2.  For control experiments, where cells were kept in the dark 
conditions, more that 95 % of the cell survival was observed 
for [1] or [2] of ~ 300 μM. These data clearly revealed that 
both complexes are non-toxic to live A549 and Hct116 cells 
when incubated in dark and showed significant light-induced 
cytotoxicity towards these cells. Further, our studies revealed 
that, in 3D tumor models a 2-fold increase in IC50 values as 
compared to the 2D cell models. One of the required 
properties for an ideal photosensitizer is that the PS should 
have a higher phototoxic index (PI = IC50 in the dark/IC50 upon 
irradiation)28 and must be activated at a specific wavelength, 
preferably in the visible or near-IR region due to the deeper 
penetration of light into tissue. In this present study, we have 
also calculated the PI for our photo-active molecules with 
excitation wavelength at λ = 450 nm. From the table S2, the 
calculated PI values for the complex 1 and 2 towards A549 
cancer cell lines are >10 % and > 4 % in 2D and 3D cell cultures 
respectively. We also had performed MTT assay studies to find 
out the specific ROS that could be accounted for the cell death. 
For this, we incubated cells in the presence of two different 
ROS scavengers, such as DMSO (OH• scavenger) and NaN3 (
1O2 
scavenger) and found that the 1O2 is the responsible species 
for the cell death (see supporting information fig. S6). Thus, 
the observed cell death was due to the in-situ (photo-induced) 
generation of 1O2 by 1 and 2. 
Single-Cell Gel electrophoresis (SCGE): Comet assay. 
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To investigate the possibility of DNA damage at cellular level, 
single-cell gel electrophoresis (SCGE) or comet assay was 
performed.43 The comet assay is based on the lyses of cells 
with non-ionic detergent like Triton-X and high-molarity 
sodium chloride. This treatment removes/dissolves cell 
membranes, cytoplasm, and nucleoplasm as well as disrupts 
nucleosomes, as most of the histone is solubilized by alkali 
solution.44 We treated A549 cells with 1 (30 µM) and 2 (30 µM) 
following photo-irradiation. For control experiments, an 
identical reaction mixture was kept in the dark conditions. 
From Fig 5a, the electrophoresis of the comet slide containing 
cells treated with 1 in presence of light reveals cleavage of 
DNA (Fig. 5a, i-iv); but no cleavage was observed in the case of 
cells treated with 1 in dark conditions (Fig. 5a, v-viii). 
Comparable results were observed for complex 2 (Fig. 5b i-iv, 
Photo-irradiated cells and Fig. 5a v-viii, cells in the dark). 
Images from fluorescence microscopy revealed the expected 
comet-like structures and the intensity of the comet tail 
relative to the head reflected the number of DNA breaks. SYBR 
green was used to visualize DNA on exposure to UV light. 
Increases in the longer and darker comet tail directly reflect 
the extent of DNA damage. The fluorescence intensity profile 
plots for 1 (Fig. 5a iii, viii) and 2 (Fig. 5b iii, viii) indicate that 
DNA damage in the tail is higher than the heads of the comets. 
The percentage of DNA damage was quantified by using 
ImageJ software (fig. S7). From this data, we conclude that the 
complex 2 caused more damage to the DNA in A549 cells than 
the complex 1. One could find the photo-irradiated samples 
cleaved cellular DNA more efficiently compared with the dark 
incubated samples. 
 
 
Figure 5. Comet images of A549 cells treated with 1 (a) and 2 (b). CLSM images (i-iv) 
photo-irradiated and (v-viii) treated in the dark. The DNA damage was visualized using 
microscope under VU light illumination. 
Cellular uptake and CLSM imaging studies. 
Since complexes 1 and 2 showed significant photo-induced 
cytotoxicity towards A549 cancer cell lines, we have further 
conducted confocal laser scanning microscopy (CLSM) studies 
to identify the cellular accumulation of these photo-toxic 
complexes. The cell imaging studies were performed by 
incubating 1 (Fig. 6a) and 2 (Fig. 6b) with live A549 cells. Co-
localization studies were then performed using commercially 
available mitotracker green. Figure 6a, b shows that neither of 
the complexes entered the cell nucleus. A close comparison of 
the merge image with mitotracker green clearly revealed the 
intracellular emission of 1 and 2 from the cytoplasm. From the 
merge images one can see that both the complexes were 
targeting the mitochondria. Also, a distinct emission was 
observed from the cell membrane, indicating that the cell 
membrane is also a target for these reagents. Literature 
reports have demonstrated that more lipophilic cationic 
reagents generally accumulate preferentially in the cell 
membrane while analogous reagents with comparable overall 
charge but relatively lower lipophilicity preference the 
nucleus.45,46 The dot-like structures with red fluorescence 
observed from the cytoplasm and cell membrane are 
reminiscent of another lipophilic Ru(II)-polypyridyl complexes 
which is observed in phospholipid bilayer of the cell 
membrane.47  
 
Figure 6. CLSM images of A549 cells incubated with 1(a) and 2 (b). Co-localization 
studies performed with mitotracker green. 
Such dot like structures, scattered in the cytoplasm, are 
attributed to localization of these reagents in cytoplasmic 
vacuoles, which are known to play a subordinate role in 
endocytosis.48,49 
Partition coefficient logP measurement.  
The partition coefficient (logP) values were calculated using 
the shake-flask method to determine the lipophilicity of 1 and 
2. Results shown in table 3 clearly reveal that the lipophilicity 
of complex 1 (logP = -1.31) is higher than 2 (logP = -1.72). The 
logP for the model Ru(II)-polypyridyl complex 
([Ru(bpy)2(dmbpy)]
2+; logP = -1.01) was also evaluated. These 
values suggest that the conjugation of the amino acids i.e., 
tyrosine and the tryptophan to the Ru(II)-polypyridyl moiety 
have certainly influenced the logP values of the final 
complexes 1 and 2.   
Table 3. Lipophilicity (logP) values obtained for 1, 2, and 
[Ru(bpy)2(dmbpy)]
2+ using the shake-flask method.31 
Complex                         1                             2                      [Ru(bpy)2(dmbpy)]
2+ 
LogP                -1.31 ± 0.02         -1.72 ± 0.05                  -1.01 ± 0.04 
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It has been previously argued that the lipophilicity of a 
complex is more important than its overall charge in 
influencing cellular internalization.50–52 The lipophilicity for the 
complexes used in this study follows the order 
[Ru(bpy)2(dmbpy)]
2+ > 1 > 2 (table 5). The trend in cellular 
internalization expected by these data was confirmed by MP-
AES (Microwave Plasma Atomic Emission Spectroscopy) 
studies (ESI, table S2) as cellular uptake follows the same order 
i.e., [Ru(bpy)2(dmbpy)]
2+ > 1 > 2. 
Wound Healing assay 
As it was discussed above the metastasis of tumors is a 
multistep biological process that allows cancer cells to get 
away from the primary tumor, survive and grow in some other 
parts of the human body.11,10,53,54 Many researchers have 
suggested that effective therapy for cancer or efficient ways of 
treating a cancer patient essentially depends on the anti-
metastatic activity of the chemotherapeutic PS drugs.3,10 from 
the MTT assay, it is evident that these two complexes have 
good potential for interrupting cancer cell proliferation in the 
presence of visible light. To further check this possibility, we 
performed wound healing assay experiments with highly 
metastatic MDA-MB231 cells. Complexes 1 and 2 were 
incubated with MDA-MB231 cells in the presence of visible 
light, while analogous model experiments were performed in 
the dark conditions. A wound was created using wound 
creating stick just prior to the addition of the complexes 1 or 2. 
Then these MDA-MB231 cells were incubated with 1 or 2 for 4 
h on photo-irradiation and then cells were kept in the dark for 
10 h. For control experiments, MDA-MB231 cells were 
incubated with 1 or 2 for 14 h in dark. Bright-field images were 
captured at different time intervals. However, images 
recorded at 0 min and after 10 h are shown in fig. 7.  fig. 7d 
(for complex 1) and fig. 7h (for complex 2) clearly reveal that 
cells that were initially irradiated for 4 h with visible light in the 
presence of 1 or 2, failed to migrate and to heal the wound. 
 
Figure 7. MDA-MB231 cells incubated with compound 1(a-d) and 2(e-h) at 0 h and 10 h. 
The graphical representation of the distance travelled by cells in the presence of 1 (i) 
and 2 (j) in the presence and absence of light. To further investigate this possibility an 
invasion assay was undertaken. 
However, figs. 7b (for complex 1) and 7f (for complex 2) reveal 
that MDA-MB231 cells that were kept in dark with complexes 
1 or 2 could migrate to the other end and the respective 
wound was almost healed. The distance travelled by the cells 
were calculated and plotted as a function of the concentration 
of reagent 1 (fig. 7i) or 2 (fig. 7j). These results indicate that 
the two Ru(II)-polypyridyl complexes do inhibit cell migration 
suggesting they may possess anti-metastatic activity. 
Invasion assay. 
As was discussed above one of the hallmarks of cancers is cell 
invasions and metastasis into nearby and distal organs 
initiated by various protein de-regulations of PTEN, MMPs, 
EGFR, and CD44. Highly metastatic cells lose cell to cell 
adherence and break off. These invade basement membrane 
and endothelial walls for entering the blood stream or lymph 
nodes. These cells are then carried away to distal organs are 
deposited and result in primary metastasis. 
Here, the cells again invade endothelial walls and basement 
membrane, gets deposited, undergo cell division, and grow to 
form tumors. The tumor-forming cells still possess the 
characteristics to invade and settle into other organs for tumor 
formation. This eventually results in a secondary metastasis. 
Therefore, invasion and metastasis are two important aspects 
that need to be controlled to prevent spreading of cancer 
throughout the human body. To assess the potential of 1 and 2 
 
Figure 8. (a) Effect of 1 and 2 on MDA-MB231 cell invasion, (b) The percentage of cells 
invaded was reduced to 17.5% with 1 and 37.5 % with 2 in the presence of light (blue 
bars). However, there was no change in the dark controls (green bars).   
in controlling cell invasion, we incubated complex treated 
highly metastatic live MDA-MB231 cells on top of matrigel and 
allowed the cell to invade in the absence (control experiment) 
and presence of visible light. The percentage of cells invaded 
was then calculated using the equation 2.  
 
         
 
equation 2. 
 
Relative to 100 % cells invasion for a control experiment, the 
percentage of cells that invaded through matrigel was 
significantly reduced when experiments were performed with 
1 (17.5 %) and 2 (37.5 %) under light irradiation conditions (fig. 
8). This experiment also revealed that the complex 1 prevents 
cell invasion more efficiently than complex 2. 
Complex 1 and 2 induces apoptosis by caspase-3 activation. 
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We next set out to elucidate the molecular mechanism 
responsible for light induced cell death by complexes 1 or 2. 
We examined if light induced cell cycle arrest occurred through 
the activation of DNA damage signalling pathways. For this, 
A549 cells were treated with complex 1 or 2 in the dark or 
under light irradiation.  It was found that there was a 
significant increase in the expression level of apoptosis marker 
caspase-3 in photo-irradiated cells (fig. 9). 
 
Figure 9. A549 cells growing in serum-containing medium were treated with 1 
and 2 for 24 h prior to lysate preparation and immunoblotting with antibodies. 
The blot was probed with primary antibodies against caspase-3. β -Actin levels 
were used as a loading control. All results are representative of two independent 
experiments. 
Whereas in the dark treated samples there was no difference 
in the expression level of caspase-3. This indicates that on 
irradiation complex 1 and 2 induce apoptosis in the A549 cells. 
As discussed earlier, exposure to visible light for cells 
incubated with 1 or 2 resulted in the generation of ROS (1O2). 
Singlet oxygen is known to damage the DNA and is also 
responsible for altering the mitochondrial trans membrane 
potential. Literature reports reveal that the pro-apoptotic 
proteins, released from mitochondria, are responsible for 
activation of caspase-3 and the cell finally leads to apoptosis. 
Thus, these photoactive compounds could be used for the 
treatment of solid tumors by specifically illuminating in the 
visible light which would not cause any ROS production in the 
dark condition. 
4. Experimental  
Materials and methods. 
All chemicals were purchased from Sigma-Aldrich unless 
otherwise indicated. 1HNMR spectra were recorded on a 
Bruker FT-NMR spectrometer at room temperature. ESI-MS 
measurements were carried out on a Waters QTof-Micro 
instrument. UV-Vis spectra were obtained by using a Cary 500 
scan UV-Vis spectrometer. Complexes 1 and 2 were converted 
into their water-soluble chloride salts via anion metathesis. 
The CT-DNA concentration per nucleotide was determined by 
absorption spectroscopy by using the molar absorption 
coefficient (6600 mol-1dm3cm-1) at 260 nm. The emission 
spectra were obtained using Edinburgh instrument Xe-900 
spectrofluoremeter. Confocal microscopy images acquired 
using Olympus Fluoview microscope. Partition coefficient 
(logP) measurements were calculated using the shake-flask (n-
octanol/water) method. The absorbance of the respective 
complex in each phase was determined using UV-Vis 
spectroscopy. ITC experiments were performed with the 
Microcal iTC200. CT-DNA concentration (0.1 mmol) and 
complexes 1 (5 mmol), 2 (5 mmol) concentrations were used 
for these experiments. All titrations were conducted in Tris-HCl 
buffer (5 mmol Tris and 25 mmol NaCl), pH = 7.4 at 25° C. The 
resulting isotherms were fitted with the one set of site binding 
model provided with Microcal iTC200. A549 and Hct116 cells 
were cultured in DMEM respectively supplemented with 10% 
FBS and penicillin/streptomycin. Cell lines were maintained at 
37 °C in an atmosphere of 5 % CO2 and routinely sub-cultured. 
Cytotoxicity tests were performed using MTT assay in 
triplicate. 
Synthesis of Complexes 1 and 2: Complexes 1 and 2 were 
synthesized following previously reported literature 
procedures. The chloride salts of 1 and 2 were obtained by 
anion metathesis of their respective PF6
ˉ salts using [nBu4N]Cl 
in acetone for improved water-solubility. Characterization data 
for respective complex are given below. 
Characterization of complex 1 (PF6)2: Yield: 58.3 % (196 mg, 
0.17 mmol).; 1H NMR (CD3CN, 500 MHz): δ 8.73 (s), 8.53 (d, J = 
8.4 Hz), 8.09 (t, J = 7.9 Hz), 7.88 (dd, J = 5.8, 2.6 Hz), 7.78-7.70 
(m), 7.64 (d, J = 7.9 Hz), 7.62-7.59 (m), 7.58 (d, J = 5.8 Hz), 7.43 
(t, J = 6.7 Hz), 7.31 (d, J = 5.5 Hz), 7.13 (dd, J = 8.5, 3.5 Hz), 6.75 
(dd, J = 8.5, 4.5 Hz), 4.86-4.80 (m), 4.18 (q, J = 8.5 Hz), 3.22 (dd, 
J = 14.0, 5.8 Hz), 3.09 (dd, J = 14.1, 8.6 Hz), 2.59 (s), 1.24 (t, J = 
7.1 Hz). ESI-HRMS (m/z) for formula: C43H39F6N7O4PRu; 
calculated 964.1743; found: 964.1740. 
Characterization of complex 2 (PF6)2: Yield: 50 % (180 mg, 
0.159 mmol). 1HNMR (CD3CN, 200 MHz): δ ppm 9.19 (d, J = 1.2 
Hz), 8.60 (s), 8.49 (d, J = 8.1 Hz), 8.38 (s), 8.06 (dd, J = 11.1, 4.6 
Hz), 7.81 (d, J = 5.7 Hz), 7.70 (d, J = 5.0 Hz), 7.57 (d, J = 5.9 Hz), 
7.52 (s), 7.39 (t, J = 6.5 Hz), 7.25 (s), 7.21 (d, J = 4.3 Hz), 7.17 
(s), 7.03 - 6.89 (m), 5.03 - 4.88 (m), 4.15 (q, J = 7.1 Hz), 3.46 - 
3.34 (m), 2.55 (s), 1.21 (t, J = 7.1 Hz). ESI-HRMS m/z (%) for 
formula C45H40N8O3Ru, calculated 841.2183; found: 841.2184. 
DNA binding titrations. 
For absorption titrations, complexes 1 and 2 were converted 
to their chloride salts by treatment with [nBu4N]Cl in acetone. 
Complex solution (10 mL of a 10 mmol stock) in Tris-HCl buffer 
was then diluted into Tris buffer to give a final concentration 
of about 5 mm Tris buffer. This was loaded into another 
identical cuvette and placed in the reference cell of the 
spectrometer. After 30 min cell equilibration, the first 
spectrum was recorded between 600-200 nm. DNA solution 
(2-5 mL) was then added to both the sample and reference cell 
and mixed. The spectrum was taken again, this time showing 
the hypochromic shift indicating the formation of a drug–DNA 
complex. The titration process was repeated until there was no 
change in the spectrum for at least four titrations, indicating 
binding saturation had been achieved. Both buffer and 
complex solutions showed insignificant emission, so no 
reference cell was used. Buffer (3 mL) was loaded in a 1 cm 
path-length luminescence cuvette; an aliquot of buffer was 
removed and replaced with the same volume of a stock 
solution of complex (final concentration 5 mm). The cuvette 
was loaded into the spectrophotometer and incubated at 25° 
C. After equilibration, the emission spectrum of the solution 
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was recorded by using the excitation wavelength characteristic 
of the complex. A concentrated stock of CT-DNA solution (2 
mL) was added to the cuvette and mixed, and then the 
emission spectrum was recorded, which showed an 
enhancement in emission. This procedure was continued until 
the emission became constant. Emission titrations were 
successfully fitted to the McGhee–von Hippel model for 
binding to an isotropic lattice. 
Isothermal Titration Calorimetry (ITC) studies. 
ITC experiments were performed with the Microcal iTC200. CT-
DNA concentration (0.1 mmol) and complexes 1 (5 mmol), and 
2 (5 mmol) concentrations were used for these experiments. 
All titrations were conducted in Tris-HCl buffer (5 mmol Tris 
and 25 mmol NaCl), pH = 7.4 at 25 °C. In each titration, CT-DNA 
was loaded into the cell and complexes 1 or 2 were taken into 
the syringe. Aliquot of 2 µL of complexes were added to the 
cell containing DNA. In each experiment, the raw isotherms 
were corrected for the heat of dilution by subtracting the 
isotherms representing the complexes injected into the Tris-
HCl buffer. The resulting isotherms were fitted with the one 
set of site binding model provided with Microcal iTC200. 
Singlet oxygen measurement studies. 
N,N-Dimethyl-4-nitrosoaniline/histidine assay. 
The singlet oxygen production was measured by the N,N-
dimethyl-4-nitroso- aniline/histidine assay based on the 
oxidation of histidine by singlet oxygen and the subsequent 
reaction of the oxidised histidine with N,N-dimethyl-4-
nitrosoaniline as previously described.45,68 The absorbance of 
the compound was adjusted to approximately 0.2 at the 
irradiation wavelength. In practice, 20 mM DMSO stock 
solution of the compound to measure were diluted in 4 mL 
PBS solution (pH 7.4) containing N,N-dimethyl-4-nitrosoaniline 
(25 μM) and histidine (0.01 M) and irradiated in fluorescence 
quartz cuvettes (width 1 cm). Bleaching of N,N-dimethyl-4-
nitrosoaniline was followed by monitoring of the absorption at 
440 nm. Negative control experiments were run by repeating 
the measurements in the absence of histidine. The same 
conditions were also used for singlet oxygen detection in 
acetonitrile, except that imidazole was used instead of 
histidine due to the low solubility of histidine in this solvent. In 
addition, the absorbance peak of N,N-dimethyl-4-
nitrosoaniline shifts to 415 nm in acetonitrile. The absorbance 
at 440/415 nm was then plotted as a function of irradiation 
time and the quantum yields of singlet oxygen formation 
(Φsample) were calculated using phenalenone as the standard 
(Φreference) with the following formula: 
MTT assay and CLSM studies.  
Cell cultures were treated with 0-300 µM solutions of 1 and 2 
in triplicate for 24 h. After incubation 5 µL of MTT reagent was 
added and incubated for 4 h. MTT = (3-(4, 5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) dissolved in serum-free 
media. The media was removed and the formazan dissolved 
using isopropanol and the absorbance at 570 nm quantified by 
the plate reader (reference 620 nm). IC50 values for the two 
complexes were found to be >300 µM. A549 cells were 
cultured in DMEM media. Cell lines were maintained at 37° C 
in an atmosphere of 5 % CO2 and routinely sub-cultured. For 
CLSM, cell cultures were grown on 6 well plate with coverslips, 
after 24 h of incubation the cells were treated with solutions 
of 1 and 2 (30 µM,) in serum containing media and incubated 
for 4 h. After incubation media was removed and cells were 
washed with 1XPBS buffer. Co-localization staining studies 
were performed using mitotracker green form life 
technologies. Cells were fluorescently imaged on a Fluoview 
confocal laser scanning microscope by using 60X oil-immersion 
lenses. Complexes 1 and 2 were excited with a laser at 442 nm 
and emission monitored at 620 nm (red) wavelengths. 
Mitotracker was excited at 490 nm. 
Wound healing (scratch motility) assay. 
MDA-MB-231 cells were cultured in Leibowitz’s L15 medium 
with 10 % FBs. 1 X 105/mL cells were seeded in 6 well plate and 
incubated for 24 h at 37 °C, 5 % CO2 incubator to form a 
monolayer. After 24 h gaps were created using pipette tip on 
the confluent monolayer and washed with media to remove 
cellular debris. The fresh medium supplemented with 10 % FBS 
was added into well and incubated with 1 and 2 (30 µM) for 4 
h to allow the uptake by cells. Following with same conditions 
one cell culture plate was photo-irradiated for 4 h and the 
other place kept in the dark conditions. The cell migration 
observed and imaged at regular intervals (0- 10 h) using Nikon 
live cell imaging microscope for 10 h. The rate of migration of 
the cells was calculated using image pro 6.0 software provided 
along with Nikon microscope. 
Comet assay. 
Live A549 cells were incubated with 1 and 2 for 4 h and 
suspended the cells into PBS buffer. This suspension of the 
cells was embedded into the low melting agarose (0.5 %) gel. 
100 µL of this mixture is poured on top of the agarose pre-
coated comet slides. The coverslip was placed on top of the 
comet slides and removed after solidification of agarose. A549 
cells were lysed with an alkaline solution over night at 4° C. 
Then slides were removed and rinsed twice with the rinsing 
solution to remove the residual amounts of excess salt and 
detergents. The comet slide incubated for 2 h in 
electrophoresis unit in 1X PBS buffer solution. Voltage (0.6 
V/cm for 25 min with current of 40 mA) applied to accumulate 
the damaged DNA at the end of the cathode. Then slide was 
removed from electrophoresis chamber and rinsed with 400 
mL of distilled water. Then the comet slide was placed in 
staining solution (syber green solution) for 20 min. Again, the 
comet slide was rinsed with 400 mL of deionized water to 
remove the excess stain. The DNA damage was visualized using 
microscope under VU light.  
Viscosity measurements. 
Viscosity studies were done in a Cannon-Manning semi micro 
viscometer (size 50) immersed in a thermostat bath 
maintained at 27 ± 1° C. The concentration of CT-DNA was 
kept constant at 1 mmol and viscosity of the CT-DNA was 
measured by increasing the concentration of the 
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ethediumbromide, 1, 2 and [Ru(bpy)3]
2+. The flow times were 
measured after thermal equilibration of at least 30 min. Each 
sample was measured three times and the averaged time was 
used in calculations. 
Invasion assay. 
2.5 X 104 MDA-MB231 highly metastatic breast cancer cells 
seeded onto each well of 24 well matrigel plate chamber. 
Below the matrigel chamber 750 µL of fetal bovine serum was 
placed as chemo-attractant for the MDA-MB231 cells to 
invade. Cells were treated with complex 1 and 2 for 4 h and 
then either exposed to dark or visible light conditions for 4 h. 
The cells were then allowed to invade the matrigel over-night 
at 37 °C in a humidified 95 % incubator. Next day, the non-
invading cells were removed using moistened cotton swabs. 
Cells were fixed with 100 % chilled methanol for 15 min and 
then washed with phosphate buffered saline (1 X PBS) three 
times. 0.4 % crystal violet was prepared and then 500 µL was 
applied into the chamber containing matrigel and invaded 
cells. After 15 min of crystal violet staining, three PBS washes 
given and then air dried. The chamber was then placed under 
an inverted microscope to count the number of invaded cells.  
Western blotting. 
Cells were lysed in TNN buffer (50 mM Tris, pH 7.5, 5mM 
EDTA, 0.5 % NP40 150 mM NaCl and 1 mM DTT), 
supplemented with protease inhibitor cocktail. The 
concentration of total protein in the cell lysate was 
determined by Bradford reagent (Thermo scientific). 40 μg of 
each protein was loaded onto 10 % SDS-PAGE, and protein was 
transferred onto PVDF membrane (Millipore) using western 
blot technique. After the completion of protein transfer, the 
membrane was blocked for 2 h at room temperature in 5 % 
BSA (MP Biomedicals). The blot was then washed with 1 X 
TBST (Tris buffer saline, 0.1 % Tween 20) 3 times, each for 5 
min. The blot was probed with primary antibodies against 
caspase-3 and β-actin (Santa Cruz) for 2 h in 1:1000 dilutions 
for caspase-3 and 1:4000 dilutions for β-actin. After washing 
the blot in 1 X TBST, secondary antibody which is conjugated 
with Horseradish peroxidase was then added in 1:4000 
dilutions in 1 X TBST buffer. The blot was then developed using 
autoradiography in X-ray film. 
Conclusions 
Two Ru(II)-polypyridyl complexes conjugated with amino acids 
tyrosine (1) and tryptophan (2) were investigated for their 
potential application as photodynamic therapeutic (PDT) 
agents. Complexes 1 and 2 showed preferential binding CT-
DNA with moderately strong binding affinity Ka = 1-5 X 10
5 mol-
1. Isothermal titration calorimetry (ITC) studies indicate that 
the reactions of both 1 and 2 with CT-DNA were entropically 
driven. Viscosity studies proved that 1 and 2 binds CT-DNA 
through groove binding. Most importantly, complexes 1 and 2 
exhibits photo-induced cytotoxic activity in the presence of 
visible light at lesser exposure time and found to be low-toxic 
in the dark conditions (the key feature required by the PDT 
agents). These two-visible light excitable Ru(II) complexes 
showed apoptosis activity, prevents the cells from invasion 
and capable of producing significant levels of 1O2 that is which 
damages the DNA upon photo-irradiation. 
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